课题基金 / 基金详情

The mechanism of CD9 and development of gene therapy for lung cancer

The mechanism of CD9 and development of gene therapy for lung cancer
CD9的作用机制及肺癌基因治疗的进展
批准号:
13671417
负责人:
HAYASHI Akihiro
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
细胞表面分子CD9被认为在信号转导途径或细胞活化、发育、增殖和运动的调节中起重要作用,尽管CD9的确切生化功能尚不清楚。本研究的目的是利用腺病毒基因转导体外肺腺癌,明确CD9表达对细胞增殖和侵袭的影响,而细胞增殖和侵袭是肿瘤转移和侵袭过程中不可或缺的一步。用重组Advs孵育人腺癌细胞A549,细胞CD9的表达呈剂量依赖性增加。细胞增殖实验和碘化丙啶流式细胞术细胞周期分析表明,CD9过表达诱导G_2/M阻滞细胞周期。通过western blotting分析,G_2/M阻滞的机制被认为是cdc2/cyclin B复合物的去磷酸化。此外,CD9的过表达抑制了MAPK/ERK的磷酸化,表明参与了MAPK信号通路。博伊登室分析表明,CD9过表达抑制了侵袭细胞的数量。总之,我们在肺腺癌体外实验中利用腺病毒基因转导证实了CD9表达对细胞增殖和侵袭的影响,而细胞增殖和侵袭是肿瘤转移和侵袭过程中不可或缺的一步。
英文摘要
The cell-surface molecule CD9 were thought to play an important role in signal transduction pathways or in the regulation of cell activation, development, proliferation, and motility, although the precise biochemical functions of CD9 remain unknown.The purpose of this study is to define the effects of CD9 expression on cell proliferation and invasion, which is an integral step in the process of tumor metastasis and invasion, using adenovirally gene transduction in lung adenocarcinoma in vitro.The human adenocarcinoma cell line A549 was incubated with recombinant Advs, and then cells increased the expression level of CD9 in a dosage-dependent manner. Cell proliferation assay and cell cycle analysis using flow cytometric assay with propidium iodide revealed that over-expression of CD9 induced G_2/M arrest in cell cycle. The mechanism of G_2/M arrest was thought to be dephosphorylation of cdc2/cyclin B complex, using western blotting. Moreover, the over expression of CD9 suppress the phosphorylation of MAPK/ERK, which was indicated participation in MAPK signaling pathway. The analysis using boyden chamber resulted the over expression of CD9 inhibited the number of invasion cells.In conclusion, we have demonstrated the effects of CD9 expression on cell proliferation and invasion, which is an integral step in the process of tumor metastasis and invasion, using adenovirally gene transduction in lung adenocarcinoma in vitro.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Fukunaga M et al.: "Adenoviral herpes simplex virus thymidine kinase gene therapy in an orthotopic lunq cancer model"Ann Thorac Surg. 73・6. 1740-1746 (2002)
Fukunaga M 等:“原位 lunq 癌症模型中的腺病毒单纯疱疹病毒胸苷激酶基因治疗”Ann Thorac Surg. 73・6 (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Terazaki Y, Yano S, Yuge K, Nagano S, Fukunaga M, Guo ZS, Komiya S, Shirouzu K, Kosai K.: "An optimal therapeutic expression level in crucial for suicide gene therapy for hepatic metastatic cancer in mice"Hepatology. 37(1). 155-163 (2003)
Terazaki Y、Yano S、Yuge K、Nagano S、Fukunaga M、Guo ZS、Komiya S、Shirouzu K、Kosai K.:“对小鼠肝转移癌自杀基因治疗至关重要的最佳治疗表达水平”肝病学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Terazaki Y et al.: "An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in mice"Hepatology. 37・1. 155-163 (2003)
Terazaki Y 等人:“最佳治疗表达水平对于小鼠肝转移癌的自杀基因治疗至关重要”,Hepatology 37・1 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fukunaga M, Takamori S, Hayashi A, Shirouzu K, Kosai K.: "Adenoviral herpes simplex virus thymidine kinase gene therapy in an orthotopic lung cancer model"Ann Thorac Surg. 73(6). 1740-1746 (2002)
Fukunaga M、Takamori S、Hayashi A、Shirouzu K、Kosai K.:“原位肺癌模型中的腺病毒单纯疱疹病毒胸苷激酶基因治疗”Ann Thorac Surg。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
海外基金